Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
lung cancer treatment
Jul 21, 2024, 12:10 |
Blog
invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma
invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…
Jul 20, 2024, 16:22 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Stephen Liu
At OncoDaily, we are excited to feature Dr. Stephen Liu, a preeminent thoracic oncologist, as…
Jul 20, 2024, 01:22 |
Blog
Brigatinib in ROS1 NSCLC
Stephen V Liu shared a post on X: ''Brigatinib in ROS1 NSCLC (Phase II Barossa…
Jul 19, 2024, 22:19 |
Insight
Gautam Mehta summarizes the FDA accelerated approval of fam-trastuzumab deruxtecan-nxki for HER2-mutated NSCLC
FDA oncology shared on X: "OCE's Gautam Mehta and colleagues summarize the FDA accelerated approval…
Jul 19, 2024, 22:19 |
Insight
Yüksel Ürün: Congratulations all new participants of the ASCO Leadership Development Program!
Yüksel Ürün shared a post by Miriam Knoll, on X, adding: "Congratulations to you and…
Jul 18, 2024, 22:37 |
Blog
ESMO Living Guideline on Oncogene-Addicted Metastatic NSCLC
European Society for Medical Oncology (ESMO) shared a post on LinkedIn: ''The new ESMO Living…
Jul 18, 2024, 15:20 |
Drugs
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Agenus shared on LinkedIn: "Today, we announced the outcomes of our End-of-Phase 2 meeting and…
Jul 18, 2024, 11:08 |
Blog
Stephen V Liu: Retrospective study looks at immunotherapy in patients with NSCLC and autoimmune condition
Stephen V Liu shared on X: "Retrospective NEJ047 study looks at immunotherapy in patients with NSCLC…
Jul 18, 2024, 10:41 |
Insight
Stephen Liu: Can we predict risk of immune related toxicity with immunotherapy for NSCLC
Stephen Liu shared a post on X about a recent paper by Fei Xing et…
Jul 18, 2024, 09:52 |
Insight
Raffaele Colombo: Trastuzumab rezetecan in patients with HER2-mutant NSCLC
Raffaele Colombo shared a post on X about a recent paper by Shun Lu et…
59
60
61
62
63
All:
857
Posts:
601 - 610
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube